Vernalis (R&D) Ltd
USPTO PatentsView assignee record - 57 granted patents across 6 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Vernalis ranks #5,992 of 49,997 tracked US assignees by granted-patent volume, with 57 patents across 6 technology areas.
- #5,992
- of 49,997 US assignees by volume
- Top 50%
- by Innovation Score (35.2/100)
- 18.8
- avg claims per patent
- -42%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R5992 · Foreign Corporation #5,992 · 57 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 57 grants
- UPPER-Q #5,992/49,997
- PHOTO-FINISH True Fabrications
- CPC-NARROW A61P · 6 areas
- INNOV-THIN 35.2/100
- CLAIMS-RICH 18.8 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -42% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: True Fabrications, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Vernalis’s 35.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Vernalis
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- DataDirect Networks · near
DataDirect Networks · near
35 score
- LiquidPower… · near
LiquidPower… · near
35 score
- MagLev Aero · near
MagLev Aero · near
35 score
- Sotera Wireless · near
Sotera Wireless · near
35 score
- Vernalis (R&D) · this assignee
Vernalis (R&D) · this assignee
35 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Vernalis's Innovation Score is 35.2/100 (top 50% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Vernalis?
Each dot is one of Vernalis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Vernalis’s own 18.8 claims/patent is ABOVE the 13.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Vernalis's grants concentrate
Vernalis (R&D) Ltd is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (11 grants) versus a trough of 1 in 2023. By volume, Vernalis sits between True Fabrications, Inc. and Zhejiang Hisun Pharmaceutical Co., Ltd..
Vernalis's three-year grant acceleration
From 2019–2021 to 2022–2024, Vernalis (R&D) Ltd moved from 27 to 5 grants (0.18x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Vernalis's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- True Fabrications
True Fabrications, Inc.
57 patents
- United States End…
United States Endoscopy Group, Inc.
57 patents
- Universita Degli…
Universita Degli Studi DI Palermo
57 patents
- Universitat Bern
Universitat Bern
57 patents
- Visible World
Visible World, LLC
57 patents
- Wargaming net
Wargaming.net Limited
57 patents
- ZF CV Systems Glo…
ZF CV Systems Global GmbH
57 patents
- Zhejiang Hisun Ph…
Zhejiang Hisun Pharmaceutical Co., Ltd.
57 patents
- Vernalis (R&D) ◀
Vernalis (R&D) Ltd
57 patents
What this shows Vernalis holds 57 patents at rank #5,990, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Vernalis
By rank, the assignees closest to #5,990 in granted patent volume.
- True Fabrications, Inc. #5,986 · 57 patents
- United States Endoscopy Group, Inc. #5,987 · 57 patents
- Universita Degli Studi DI Palermo #5,988 · 57 patents
- Universitat Bern #5,989 · 57 patents
- Visible World, LLC #5,991 · 57 patents
- Wargaming.net Limited #5,992 · 57 patents
- ZF CV Systems Global GmbH #5,993 · 57 patents
- Zhejiang Hisun Pharmaceutical Co., Ltd. #5,994 · 57 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Vernalis's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Vernalis, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Vernalis ranks #307 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (35 here).
Similar claim depth
Nearest assignees by average claims per patent (18.8 here).
Vernalis's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 Top 50% higher than 50% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 6 | 10.5% |
| 2016 | 5 | 8.8% |
| 2017 | 10 | 17.5% |
| 2018 | 4 | 7.0% |
| 2019 | 11 | 19.3% |
| 2020 | 10 | 17.5% |
| 2021 | 6 | 10.5% |
| 2022 | 3 | 5.3% |
| 2023 | 1 | 1.8% |
| 2024 | 1 | 1.8% |
Which technologies does Vernalis (R&D) Ltd patent most?
Top 6 of 6 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Vernalis (R&D) Ltd's patent record in context - here's where to go next.
- Vernalis (R&D) Ltd's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #5,992 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Vernalis (R&D) Ltd against True Fabrications, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 35.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.